HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (24) Citing Articles via Google Scholar Google Scholar Articles by Christofidou-Solomidou, M. Articles by Muzykantov, V. R. Search for Related Content PubMed PubMed Citation Articles by Christofidou-Solomidou, M. Articles by Muzykantov, V. R.

EDITORIAL FOCUS

PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress

¹Pulmonary Critical Care Division, Department of Medicine and ²Institute of Environmental Medicine, ⁴Department of Pharmacology, University of Pennsylvania, Philadelphia 19104; and ³Department of Pathology, Temple University Hospital, Philadelphia, Pennsylvania 19140

Submitted 21 January 2003 ; accepted in final form 10 March 2003

Targeted delivery of drugs to vascular endothelium promises more effective and specific therapies in many disease conditions, including acute lung injury (ALI). This study evaluates the therapeutic effect of drug targeting to PECAM (platelet/endothelial cell adhesion molecule-1) in vivo in the context of pulmonary oxidative stress. Endothelial injury by reactive oxygen species (e.g., H₂O₂) is involved in many disease conditions, including ALI/acute respiratory distress syndrome and ischemia-reperfusion. To optimize delivery of antioxidant therapeutics, we conjugated catalase with PECAM antibodies and tested properties of anti-PECAM/catalase conjugates in cell culture and mice. Anti-PECAM/catalase, but not an IgG/catalase counterpart, bound specifically to PECAM-expressing cells, augmented their H₂O₂-degrading capacity, and protected them against H₂O₂ toxicity. Anti-PECAM/catalase, but not IgG/catalase, rapidly accumulated in the lungs after intravenous injection in mice, where it was confined to the pulmonary endothelium. To test its protective effect, we employed a murine model of oxidative lung injury induced by glucose oxidase coupled with thrombomodulin antibody (anti-TM/GOX). After intravenous injection in mice, anti-TM/GOX binds to pulmonary endothelium and produces H₂O₂, which causes lung injury and 100% lethality within 7 h. Coinjection of anti-PECAM/catalase protected against anti-TM/GOX-induced pulmonary oxidative stress, injury, and lethality, whereas polyethylene glycol catalase or IgG/catalase conjugates afforded only marginal protective effects. This result validates vascular immunotargeting as a prospective strategy for therapeutic interventions aimed at immediate protective effects, e.g., for augmentation of antioxidant defense in the pulmonary endothelium and treatment of ALI.

drug delivery; acute lung injury; platelet/endothelial cell adhesion molecule

This article has been cited by other articles:

				C. Garnacho, V. Shuvaev, A. Thomas, L. McKenna, J. Sun, M. Koval, S. Albelda, V. Muzykantov, and S. Muro RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1 Blood, March 15, 2008; 111(6): 3024 - 3033. [Abstract] [Full Text] [PDF]

				J. C. Lee, F. Bhora, J. Sun, G. Cheng, E. Arguiri, C. C. Solomides, S. Chatterjee, and M. Christofidou-Solomidou Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemia-reperfusion injury Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L255 - L265. [Abstract] [Full Text] [PDF]

				K. Nowak, S. Weih, R. Metzger, R. F. Albrecht II, S. Post, P. Hohenberger, M.-M. Gebhard, and S. M. Danilov Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L162 - L169. [Abstract] [Full Text] [PDF]

				S. Muro, M. Mateescu, C. Gajewski, M. Robinson, V. R. Muzykantov, and M. Koval Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteins Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L809 - L817. [Abstract] [Full Text] [PDF]

				Y. Arita, S. H. Harkness, J. A. Kazzaz, H.-c. Koo, A. Joseph, J.A. Melendez, J. M. Davis, A. Chander, and Y. Li Mitochondrial localization of catalase provides optimal protection from H2O2-induced cell death in lung epithelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L978 - L986. [Abstract] [Full Text] [PDF]

				B.-S. Ding, T. Dziubla, V. V. Shuvaev, S. Muro, and V. R. Muzykantov Advanced drug delivery systems that target the vascular endothelium. Mol. Interv., April 1, 2006; 6(2): 98 - 112. [Abstract] [Full Text] [PDF]

				S. Muro, C. Gajewski, M. Koval, and V. R. Muzykantov ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs Blood, January 15, 2005; 105(2): 650 - 658. [Abstract] [Full Text] [PDF]

				Y. Li and J. M. Davis Delivering antioxidants by zip code Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L281 - L282. [Full Text] [PDF]